MODD vs. PROF, LUCD, OBIO, AVR, INFU, KRMD, SKIN, MGRM, ICAD, and NSPR
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Profound Medical (PROF), Lucid Diagnostics (LUCD), Orchestra BioMed (OBIO), Anteris Technologies Global (AVR), InfuSystem (INFU), KORU Medical Systems (KRMD), Beauty Health (SKIN), Monogram Orthopaedics (MGRM), iCAD (ICAD), and InspireMD (NSPR). These companies are all part of the "medical equipment" industry.
Modular Medical vs.
Profound Medical (NASDAQ:PROF) and Modular Medical (NASDAQ:MODD) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, analyst recommendations, valuation, earnings, institutional ownership and community ranking.
47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 27.5% of Modular Medical shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 20.5% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Modular Medical has lower revenue, but higher earnings than Profound Medical. Profound Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.
Profound Medical currently has a consensus price target of $11.50, indicating a potential upside of 138.10%. Given Profound Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Profound Medical is more favorable than Modular Medical.
Profound Medical has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, Modular Medical has a beta of 0.33, suggesting that its share price is 67% less volatile than the S&P 500.
In the previous week, Profound Medical had 9 more articles in the media than Modular Medical. MarketBeat recorded 12 mentions for Profound Medical and 3 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.16 beat Profound Medical's score of 0.18 indicating that Modular Medical is being referred to more favorably in the news media.
Profound Medical received 39 more outperform votes than Modular Medical when rated by MarketBeat users. However, 100.00% of users gave Modular Medical an outperform vote while only 73.21% of users gave Profound Medical an outperform vote.
Modular Medical has a net margin of 0.00% compared to Profound Medical's net margin of -349.41%. Profound Medical's return on equity of -85.22% beat Modular Medical's return on equity.
Summary
Profound Medical beats Modular Medical on 11 of the 18 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MODD) was last updated on 5/2/2025 by MarketBeat.com Staff
